ask="19.50"
ask_size="800"
average_daily_volume="156666"
bid="16.05"
bid_size="500"
book_value="6.55"
change="-0.25"
change_from_200_day_moving_average="0.67"
change_from_50_day_moving_average="-0.36"
change_from_52_week_high="-7.03"
change_From_52_week_low="4.15"
change_in_percent="-1.52%"
close="16.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.68"
ebitda="-63.46M"
eps_estimate_current_year="-3.02"
eps_estimate_next_quarter="-0.73"
eps_estimate_next_year="-3.05"
ex_dividend_date="N/A"
float_shares="11787000"
high="16.48"
high_52_weeks="23.20"
last_trade_date="1/20/2017"
last_trade_price="16.17"
last_trade_size="9202"
last_trade_time="4:00pm"
low="16.05"
low_52_weeks="12.02"
market_capitalization="355.45M"
moving_average_200_day="15.50"
moving_average_50_day="16.53"
name="Adamas Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="32.71"
open="16.46"
pe_ratio="N/A"
peg_ratio="-0.07"
percent_change_from_200_day_moving_average="+4.35%"
percent_change_from_50_day_moving_average="-2.20%"
percent_change_from_52_week_high="-30.30%"
percent_change_from_52_week_low="+34.53%"
previous_close="16.42"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.51"
price_per_sales="340.84"
revenue="1.06M"
shares_outstanding="21982000"
short_ratio="27.37"
stock_exchange="NGM"
symbol="ADMS"
volume="72801"
weeks_range_52="12.02 - 23.20"
